Ottawa – The Public Health Agency of Canada (PHAC) and its partners are focused on keeping people and animals in Canada safe and ensuring Canada is ready for any potential health threats. This includes taking proactive measures to protect the health of people in Canada by authorizing and securing the supply of a human vaccine against avian influenza as part …
Addressing chronic pain with treatment
Ottawa – Pain is an unpleasant sensory and emotional experience typically associated with physical damage to the body. Chronic pain is when the pain lasts longer than 3 months. Sometimes chronic pain can occur: without a known cause after an injury has healed after a condition has been treated The World Health Organization now recognizes chronic pain as a disease …
UNITE TO HEAL THIS RAMADAN
Karachi – In just two weeks, the Ramadan moon will rise in the sky and bring with it a time of reflection, worship, and opportunities to give back. This is why millions around the world choose to give their obligatory, annual Zakat, during the blessed month of Ramadan. While a religious duty, Zakat is also a powerful tool to bring relief …
Addressing Growing Concern of Syphilis in Canada
The Public Health Challenge of Syphilis Supporting positive sexual health outcomes for people in Canada means taking swift and coordinated action to address the rise in various sexually transmitted and blood-borne infections (STBBI). Of particular concern among these infections is syphilis. Despite being both preventable and curable, syphilis rates have been rising in recent years. Between 2018 and 2023, infectious syphilis cases …
Clinical Practice Guideline for Management of Perinatal Mood
Ottawa – Perinatal mental health refers to a person’s mental wellbeing during pregnancy, the postpartum period and first year after childbirth. A perinatal mood, anxiety or related disorder is a treatable mental health condition or illness that occurs during the perinatal period. These include major depressive disorders, anxiety disorders, obsessive-compulsive disorders, post-traumatic stress disorders and psychosis. If left unaddressed, they …
Treating Mood & Anxiety Disorders in Pregnancy, Postpartum
Toronto – Welcoming a new baby is a major life transition – one that can be both physically taxing and psychologically taxing. It is normal to feel a range of emotions, from joy and excitement to anxiety to sadness. Mental health issues can happen in pregnancy and postpartum. One in five people will experience a perinatal mood, anxiety, and related …
Moderna to develop mRNA pandemic influenza vaccines
Ottawa – Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, respiratory syncytial virus (RSV), and norovirus—and its risk to public health, according to the Centers for Disease Control and Prevention (CDC), remains low. But that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even probable. The Department of Health and Human Services (HHS), of which the …
Canada invests $6m to drive growth in BC’s life sciences sector
Vancouver – British Columbia is home to a thriving life sciences sector, with over 2,000 companies employing more than 20,000 people across the province. However, the lack of specialized research facilities in BC’s Lower Mainland means that early-stage life sciences companies do not have the necessary resources to expand and advance their innovations. Harjit S. Sajjan, Minister of Emergency Preparedness …
Canada to strengthen health systems in Africa, Asia, Americas
Ottawa – Ahmed Hussen, Minister of International Development, announced the following 14 projects, totaling $248.2 million. Project: TRUST: Women’s Voices, Midwifery Leadership for Resilient Health Partner: Canadian Association of Midwives Funding: $8,075,000 over 5 years This project aims to improve the agency of women and girls, including marginalized populations, to exercise their sexual and reproductive health and rights, primarily in …
BionTech shows progress on its pipeline of mRNA therapeutics
MAINZ — BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) presented its 2025 strategic priorities and progress on the Company’s pipeline of mRNA therapeutics, immunomodulators, and targeted therapies at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California. “We aim to develop BioNTech into a global immunotherapy powerhouse with the potential to improve the standard of care with innovative oncology products …